NuVasive, Inc.
NUVA
NUVA was delisted on the 31st of August, 2023.
237 hedge funds and large institutions have $2.65B invested in NuVasive, Inc. in 2022 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 93 increasing their positions, 75 reducing their positions, and 31 closing their positions.
310% more call options, than puts
Call options by funds: $2.02M | Put options by funds: $492K
24% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 75
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 31
3% less funds holding
Funds holding: 245 → 237 (-8)
8% less capital invested
Capital invested by funds: $2.88B → $2.65B (-$223M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$52.3M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$32.4M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$20.8M |
| 4 |
BlackRock
New York
|
+$18.7M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$18.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$40.9M |
| 2 |
Goldman Sachs
New York
|
-$26.1M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$18.6M |
| 4 |
Jennison Associates
New York
|
-$18.3M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$17.2M |
NUVA Hedge Fund Activity: Q2 2022 in Review
237 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in NuVasive, Inc. (NUVA) for Q2 2022, worth a combined $2.65B — down 7.8% from $2.88B a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of NUVA and 29 opened new positions — a net loss of 2 holders — while 75 trimmed existing stakes and 93 added.
The largest buyer was Citigroup, adding an estimated $52.3M. The largest seller was Bank of America, cutting an estimated $40.9M.
- 237 institutional investors held NuVasive, Inc. (NUVA) as of Q2 2022, down from 245 in Q1 2022.
- Funds reported $2.65B of NuVasive, Inc. stock for Q2 2022, down 7.8% quarter-over-quarter.
- 29 funds opened new NuVasive, Inc. positions in Q2 2022 and 31 closed out, a net change of -2 holders.
- The largest NuVasive, Inc. buyer in Q2 2022 was Citigroup, an estimated $52.3M added.
- The largest NuVasive, Inc. seller in Q2 2022 was Bank of America, an estimated $40.9M sold.
Based on aggregated 13F filings for Q2 2022.